Sign in
4

Changes in Ownership

Prime Medicine, Inc. Filed Acc 0001894562-25-000048

Options or other derivatives

  • Director acquired 387,000 shares (grant or award)
  • Director returned 387,000 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Marrazzo Jeffrey D Director 2025-08-01 Returned to the company · Stock Option (right to buy) −92,000 0 D
Marrazzo Jeffrey D Director 2025-08-01 Grant or award · Stock Option (right to buy) +92,000 92,000 D
Marrazzo Jeffrey D Director 2025-08-01 Returned to the company · Stock Option (right to buy) −250,000 0 D
Marrazzo Jeffrey D Director 2025-08-01 Grant or award · Stock Option (right to buy) +250,000 250,000 D
Marrazzo Jeffrey D Director 2025-08-01 Returned to the company · Stock Option (right to buy) −45,000 0 D
Marrazzo Jeffrey D Director 2025-08-01 Grant or award · Stock Option (right to buy) +45,000 45,000 D
Loading xslF345X05/wk-form4_1754440996.xml…